Cargando…

Prognostic value of circulating chromogranin A levels in acute coronary syndrome: reply

Detalles Bibliográficos
Autores principales:	Røsjø, Helge, Omland, Torbjørn, Jansson, Anna M., Caidahl, Kenneth, Flyvbjerg, Allan
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2010
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800921/ https://www.ncbi.nlm.nih.gov/pubmed/19906689 http://dx.doi.org/10.1093/eurheartj/ehp469

Ejemplares similares

Prognostic value of circulating chromogranin A levels in acute coronary syndromes
por: Jansson, Anna M., et al.
Publicado: (2009)

The association between circulating adiponectin levels, lung function and adiposity in subjects from the general population; data from the Akershus Sleep Apnea Project
por: Caspersen, Nina F., et al.
Publicado: (2018)

Subclinical Myocardial Injury and Risk of COVID-19 in the General Population: The Trøndelag Health Study
por: Lyngbakken, Magnus Nakrem, et al.
Publicado: (2021)

Prognostic Value of Circulating MicroRNA-210 Levels in Patients with Moderate to Severe Aortic Stenosis
por: Røsjø, Helge, et al.
Publicado: (2014)

Long-term prognostic value of mitral regurgitation in acute coronary syndromes
por: Persson, Anita, et al.
Publicado: (2010)

Prognostic value of high-sensitivity troponin T levels in patients with ventricular arrhythmias and out-of-hospital cardiac arrest: data from the prospective FINNRESUSCI study
por: Røsjø, Helge, et al.
Publicado: (2014)

Circulating MicroRNAs and Aerobic Fitness – The HUNT-Study
por: Bye, Anja, et al.
Publicado: (2013)

Low Efficacy of Chromogranin A Elimination by Therapeutic Plasma Exchange for Treatment of Chromogranin A Tubulopathy
por: Hakroush, Samy, et al.
Publicado: (2021)

Prognostic value of cardiac biomarkers and National Early Warning Score 2 in acute dyspnoea
por: Berge, Kristian, et al.
Publicado: (2022)

Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome
por: Røsjø, Helge, et al.
Publicado: (2010)

Associations between circulating microRNAs and lipid-rich coronary plaques measured with near-infrared spectroscopy
por: Sæther, Julie Caroline, et al.
Publicado: (2023)

Cardiac troponin T levels and exercise stress testing in patients with suspected coronary artery disease: the Akershus Cardiac Examination (ACE) 1 study
por: Røysland, Ragnhild, et al.
Publicado: (2012)

Altered Chromogranin A Circulating Levels in Meniere's Disease
por: Teggi, Roberto, et al.
Publicado: (2015)

Genetic landscape of prognostic value in pancreas ductal adenocarcinoma microenvironment—reply
por: Pu, Ning, et al.
Publicado: (2020)

Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial
por: Lyngbakken, Magnus Nakrem, et al.
Publicado: (2020)

Tobacco Consumption and High‐Sensitivity Cardiac Troponin I in the General Population: The HUNT Study
por: Skranes, Julia Brox, et al.
Publicado: (2022)

Prognostic value of histological and biological markers in pharyngeal squamous cell carcinoma – a reply
por: Guerry, M, et al.
Publicado: (2000)

N-terminal pro-B-type natriuretic peptide as a prognostic indicator for 30-day mortality following out-of-hospital cardiac arrest: a prospective observational study
por: Aarsetøy, Reidun, et al.
Publicado: (2020)

Reply to the Letter by Ertem et al. Entitled ‘Is Coronary Circulation the Most Important Parameter for Right Ventricular Functions?’
por: Altunkas, Fatih, et al.
Publicado: (2015)

Biological variation, reference change values and index of individuality of GDF-15
por: Sithiravel, Cindhya, et al.
Publicado: (2022)

Established Cardiovascular Biomarkers Provide Limited Prognostic Information in Unselected Patients Hospitalized With COVID-19
por: Omland, Torbjørn, et al.
Publicado: (2020)

Reply on “Vitamin D and coronary atherosclerosis”
por: Lee, Ah-Young, et al.
Publicado: (2017)

Diagnostic and Prognostic Properties of Osteoprotegerin in Patients with Acute Dyspnoea: Observations from the Akershus Cardiac Examination (ACE) 2 Study
por: Røysland, Ragnhild, et al.
Publicado: (2016)

Prognostic factors in gastric carcinoma - reply
por: Setälä, Leena, et al.
Publicado: (1997)

Prognostic value of chromogranin A in patients with GET/NEN in the pancreas and the small intestine
por: Fuksiewicz, Małgorzata, et al.
Publicado: (2018)

Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 study
por: Winther, Jacob A., et al.
Publicado: (2017)

Reply: Randomised studies with translational end points are required to further elucidate the prognostic and predictive value of CA IX
por: Hussain, S A, et al.
Publicado: (2007)

Reply: The value of case–control audits of screening
por: Sasieni, P, et al.
Publicado: (2004)

Characterisation of circulating chromogranin A in human cancer patients.
por: Corti, A., et al.
Publicado: (1996)

Diagnostic Value of Circulating Chromogranin A for Neuroendocrine Tumors: A Systematic Review and Meta-Analysis
por: Yang, Xin, et al.
Publicado: (2015)

Serum chromogranin A levels are associated with the SYNTAX score in coronary artery disease
por: Çelikkol, Aliye, et al.
Publicado: (2023)

Valuing Knowledge: a Reply to the Epistemological Perspective on the Value of Gain-of-Function Experiments
por: Evans, Nicholas Greig
Publicado: (2014)

Reply: Value of tyrosinase RT–PCR in melanoma prognosis
por: Gogas, H
Publicado: (2003)

Author`s Reply
por: Rivas, Marcella, et al.
Publicado: (2016)

Reply to Letter to the Editor: “Clinical Value of Tp-e/QTc Ratio in Patients Undergoing Coronary Angiography for Acute Coronary Syndrome”
por: Yayla, Kadriye Gayretli, et al.
Publicado: (2022)

Percutaneous Revascularization of Patients with History of Coronary Bypass Graft: Reply
por: Behboudi, Fatemeh
Publicado: (2011)

Secretogranin II; a Protein Increased in the Myocardium and Circulation in Heart Failure with Cardioprotective Properties
por: Røsjø, Helge, et al.
Publicado: (2012)

Regulation of tumor growth by circulating full-length chromogranin A
por: Curnis, Flavio, et al.
Publicado: (2016)

Prognostic value of right ventricular refractory period heterogeneity in Brugada syndrome. Independent predictor or part of something more complex? Author's reply
por: Rossi, Andrea, et al.
Publicado: (2022)

Reply: A morpho-molecular prognostic model for hepatocellular carcinoma
por: Srivastava, S, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nva627rb294reno5cq3kr8kunk